Oncolytics Biotech Inc. (ONCY) in Focus: Stock Rises 9.5%


Oncolytics Biotech Inc. (ONCY) was a big mover last session, as the company saw its shares rise nearly 10% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $1.25 to $1.37 in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Oncolytics Biotech currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other attractive players in the healthcare industry include Agenus Inc. (AGEN), Actelion Ltd. (ALIOF) and Biogen Idec Inc. (BIIB), all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ONCOLYTICS BIOTECH INC (ONCY): Free Stock Analysis Report

AGENUS INC (AGEN): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

Zacks Investment Research

View Comments (0)